2021
DOI: 10.14218/jcth.2020.00131
|View full text |Cite
|
Sign up to set email alerts
|

Gut Microbiota in Metabolic-associated Fatty Liver Disease and in Other Chronic Metabolic Diseases

Abstract: The gut microbiome plays a key role in the health-disease balance in the human body. Although its composition is unique for each person and tends to remain stable throughout lifetime, it has been shown that certain bacterial patterns may be determining factors in the onset of certain chronic metabolic diseases, such as type 2 diabetes mellitus (T2DM), obesity, metabolic-associated fatty liver disease (MAFLD), and metabolic syndrome. The gut-liver axis embodies the close relationship between the gut and the liv… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
23
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 20 publications
(24 citation statements)
references
References 97 publications
(207 reference statements)
1
23
0
Order By: Relevance
“…During the last years, a substantial number of studies on the impact of gut microbiota and host health have been conducted, showing that the disruption of gut microbiota homeostasis (called dysbiosis) is related to a large array of diseases. These include metabolic diseases like obesity and metabolic-associated fatty liver disease [ 7 , 8 ], irritable bowel syndrome [ 9 ] as well as several immune-related diseases like allergies [ 10 ], autoimmune diseases [ 11 ], and inflammatory bowel disease [ 12 ]. These latter associations illustrate the direct interaction between gut microbiota and the immune system.…”
Section: Gut Microbiota and Immune Systemmentioning
confidence: 99%
“…During the last years, a substantial number of studies on the impact of gut microbiota and host health have been conducted, showing that the disruption of gut microbiota homeostasis (called dysbiosis) is related to a large array of diseases. These include metabolic diseases like obesity and metabolic-associated fatty liver disease [ 7 , 8 ], irritable bowel syndrome [ 9 ] as well as several immune-related diseases like allergies [ 10 ], autoimmune diseases [ 11 ], and inflammatory bowel disease [ 12 ]. These latter associations illustrate the direct interaction between gut microbiota and the immune system.…”
Section: Gut Microbiota and Immune Systemmentioning
confidence: 99%
“…Alterations in the composition of the gut flora alter host–microbiota interactions and lead to the dysregulation of the gut immune system, which is associated with the pathogenesis of several diseases, including type 2 DM, obesity, and MAFLD [ 21 ]. The gut microbiota primarily affects the host through immunological, metabolic-dependent, and metabolic-independent pathways [ 22 ].…”
Section: Introductionmentioning
confidence: 99%
“…Several potentially beneficial anaerobic commensal bacteria, such as Faecalibacterium prausnitzii , Akkermansia muciniphila , and Rosburia intestinalis , have been found to be enriched after bariatric surgery 38 . Family members share similar microbial signatures, and it is thought that the composition of the gut microbiota is at least partly influenced by genetics 37 . Furthermore, small intestinal bacterial overgrowth, increased gut permeability, and gut-derived metabolites are related to the development of NAFLD/MAFLD 2,39 …”
Section: Pathophysiology Of Nafld/mafldmentioning
confidence: 99%
“…38 Family members share similar microbial signatures, and it is thought that the composition of the gut microbiota is at least partly influenced by genetics. 37 Furthermore, small intestinal bacterial overgrowth, increased gut permeability, and gut-derived metabolites are related to the development of NAFLD/MAFLD. 2,39…”
Section: Gut Microbiotamentioning
confidence: 99%